Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Raffles Medical Group ( (SG:BSL) ).
Raffles Medical Group Ltd recently held its 36th Annual General Meeting at Suntec Singapore International Convention & Exhibition Centre. The meeting was attended by key company directors and executives, along with auditors and legal advisors. The gathering focused on reviewing the company’s performance and strategic direction, which could have implications for its market positioning and stakeholder interests.
The most recent analyst rating on (SG:BSL) stock is a Buy with a S$1.12 price target. To see the full list of analyst forecasts on Raffles Medical Group stock, see the SG:BSL Stock Forecast page.
More about Raffles Medical Group
Raffles Medical Group Ltd operates in the healthcare industry, providing a wide range of medical services including primary care, specialist services, and hospital management. The company is focused on delivering comprehensive healthcare solutions to its clients in Singapore and the region.
Average Trading Volume: 3,247,161
Technical Sentiment Signal: Buy
Current Market Cap: S$1.9B
For detailed information about BSL stock, go to TipRanks’ Stock Analysis page.